Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Nutrients
|
December 28, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study
Daniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2021
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Ligand After <sup>223</sup>Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
Oliver Sartor, Christian la Fougère, Markus Essler, et al.
Cancer Research and Treatment
|
March 13, 2015
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
Daniel Keizman, Keren Rouvinov, Avishay Sella, et al.
Nutrients
|
August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study
Daniel Keizman, Moshe Frenkel, Avivit Peer, et al.
JAMA Oncology
|
July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
Tal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
Cancer Discovery
|
September 3, 2021
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors
Ithai Waldhorn, Roy Holland, Tal Goshen-Lago, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2012
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
Daniel Keizman, Maya Ish-Shalom, Roberto Pili, et al.
The Oncologist
|
January 20, 2025
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer
Emiliano Calvo, Bernard Doger, Joan Carles, et al.
Clinical Genitourinary Cancer
|
May 24, 2016
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma
Daniel Keizman, Maya Ish-Shalom, Avishay Sella, et al.
European Urology Open Science
|
November 10, 2022
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
Anders Bjartell, Luis Costa, Gero Kramer, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Nutrients
|
December 28, 2021
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II Study
Daniel Keizman, Moshe Frenkel, Avivit Peer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 25, 2021
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Ligand After <sup>223</sup>Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
Oliver Sartor, Christian la Fougère, Markus Essler, et al.
Cancer Research and Treatment
|
March 13, 2015
Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
Daniel Keizman, Keren Rouvinov, Avishay Sella, et al.
Nutrients
|
August 26, 2023
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study
Daniel Keizman, Moshe Frenkel, Avivit Peer, et al.
JAMA Oncology
|
July 8, 2021
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
Tal Goshen-Lago, Ithai Waldhorn, Roy Holland, et al.
Cancer Discovery
|
September 3, 2021
Six-Month Efficacy and Toxicity Profile of BNT162b2 Vaccine in Cancer Patients with Solid Tumors
Ithai Waldhorn, Roy Holland, Tal Goshen-Lago, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2012
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma
Daniel Keizman, Maya Ish-Shalom, Roberto Pili, et al.
The Oncologist
|
January 20, 2025
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer
Emiliano Calvo, Bernard Doger, Joan Carles, et al.
Clinical Genitourinary Cancer
|
May 24, 2016
Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma
Daniel Keizman, Maya Ish-Shalom, Avishay Sella, et al.
European Urology Open Science
|
November 10, 2022
Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry
Anders Bjartell, Luis Costa, Gero Kramer, et al.
Page
of 5